Evidence map›Paper›PMID 41390906›Full record

ArticleScientific reports2025

Time-managed PAPR use enables a balanced approach to infection control and personal freedom.

Yusaku Fujii

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Yusaku FujiiGunma University, Kiryu, Japan. fujii@gunma-u.ac.jp.

Funding

Japan Society for the Promotion of Science 25K00735
6 · The paper itself

Abstract

Full lockdowns during airborne-disease pandemics impose substantial socio-economic costs. To address this, to the best of the author's knowledge, three prior contributions were made for the first time: (i) proposed a concept in which medical-grade Powered Air-Purifying Respirators (PAPRs) used by the general public can serve as an engineering alternative to lockdowns; (ii) disclosed a proof-of-concept PAPR with aerosol-blocking performance comparable to medical devices at a parts cost of USD 40; and (iii) demonstrated via mathematical modeling that if more than 55% of the population wears PAPRs continuously-or if everyone wears them intermittently to a moderate extent-the effective reproduction number R

Indexed as

COVID-19Infection ControlHumansModels, TheoreticalPandemicsSARS-CoV-2Airborne infectious diseaseEngineering alternative to lockdownNon-pharmaceutical intervention (NPI)PAPR for everyonePAPR wearing-status networked management system (PWS-NET)Powered air-purifying respirator (PAPR)Saved allowance time (SAT)Verifiable record of AI output

Identifiers

PMID41390906
PMCPMC12827256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.